Entyvio
Payments companies reported to CMS as associated with Entyvio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Entyvio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Entyvio
These are the largest totals companies reported as associated with Entyvio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amar Naik | Des Plaines, IL | Gastroenterology (Internal Medicine) | $202,177.58 |
| Joanna Lopez | Miami, FL | Gastroenterology (Internal Medicine) | $183,384.09 |
| Anish Patel | Fort Sam Houston, TX | Gastroenterology (Internal Medicine) | $163,803.83 |
| Gerald Dryden | Louisville, KY | Gastroenterology (Internal Medicine) | $146,250.78 |
| Peter Mcnally | Ft Carson, CO | Gastroenterology (Internal Medicine) | $105,781.54 |
| Jennifer Seminerio-Diehl | Orlando, FL | Gastroenterology (Internal Medicine) | $103,695.29 |
| Adam Stein | Chicago, IL | Gastroenterology (Internal Medicine) | $93,758.50 |
| Parambir Dulai | Chicago, IL | Gastroenterology (Internal Medicine) | $91,885.65 |
| Emad Mansoor | Cleveland, OH | Internal Medicine | $83,706.62 |
| Udayakumar Navaneethan | Saint Petersburg, FL | Gastroenterology (Internal Medicine) | $82,750.30 |
Prescribed Entyvio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.